DV
Dividend Vision

AXSM — Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. (AXSM)

Total return is 2344.7% over the past 10.7 years, 2000.5 points ahead of SPY at 344.2%. Its deepest 1-year drawdown was 18.5%.

AXSM is a single-stock equity holding in Axsome Therapeutics, a biopharmaceutical company, rather than a diversified ETF. The holding generates no distributions and carries the concentration risk inherent to individual stock investments. This security appeals primarily to investors seeking direct exposure to a specific company rather than those seeking dividend income or broad portfolio diversification.

AXSM key facts

Asset type
Stock
Asset class
Equity
Inception date
11/19/2015
Distribution frequency
None
Last close
$213.67
Market cap
$11,192,208,384
Average volume
476327.0
Beta
0.726
Payout ratio
0.0
Forward P/E
333.3333
EPS
$-3.74